Literature DB >> 7612631

Isolated RNA binding domain of a class I tRNA synthetase.

A J Gale1, P Schimmel.   

Abstract

Class I tRNA synthetases typically have two major domains consisting of a class-defining N-terminal nucleotide binding fold, which contains the active site, and an idiosyncratic C-terminal domain, which in many instances provides for interactions with the tRNA anticodon. Whether the C-terminal domain can function in specific RNA binding when disconnected from the catalytic core is not known. We fused the anticodon binding domain of Escherichia coli methionyl tRNA synthetase to maltose binding protein. This fusion protein and the released, isolated domain are stable and have native-like structural characteristics, as shown by circular dichroism and thermal denaturation studies. Both the fusion protein and the isolated domain bind specifically to a small RNA hairpin oligonucleotide that recapitulates the anticodon stem-loop of tRNAfMet. Neither protein binds to an RNA hairpin with a point mutation in the anticodon trinucleotide. The binding specificity and affinity of these proteins duplicate those of the interaction between methionyl tRNA synthetase and the anticodon stem-loop oligonucleotide. Thus, the anticodon binding domain is functionally independent of the class-defining catalytic core and can be joined to another protein with little change in RNA binding characteristics.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7612631     DOI: 10.1021/bi00027a042

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  10 in total

1.  Two conformations of a crystalline human tRNA synthetase-tRNA complex: implications for protein synthesis.

Authors:  Xiang-Lei Yang; Francella J Otero; Karla L Ewalt; Jianming Liu; Manal A Swairjo; Caroline Köhrer; Uttam L RajBhandary; Robert J Skene; Duncan E McRee; Paul Schimmel
Journal:  EMBO J       Date:  2006-05-25       Impact factor: 11.598

2.  Activation of microhelix charging by localized helix destabilization.

Authors:  R W Alexander; B E Nordin; P Schimmel
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

3.  An inserted region of leucyl-tRNA synthetase plays a critical role in group I intron splicing.

Authors:  Seung Bae Rho; Tommie L Lincecum; Susan A Martinis
Journal:  EMBO J       Date:  2002-12-16       Impact factor: 11.598

4.  Subtle atomic group discrimination in the RNA minor groove.

Authors:  M Frugier; P Schimmel
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

5.  Analysis of bacteriophage N protein and peptide binding to boxB RNA using polyacrylamide gel coelectrophoresis (PACE).

Authors:  C D Cilley; J R Williamson
Journal:  RNA       Date:  1997-01       Impact factor: 4.942

6.  An engineered amino-terminal domain of yeast phosphoglycerate kinase with native-like structure.

Authors:  M A Sherman; Y Chen; M T Mas
Journal:  Protein Sci       Date:  1997-04       Impact factor: 6.725

7.  Through-bond correlation of imino and aromatic resonances in 13C-, 15N-labeled RNA via heteronuclear TOCSY.

Authors:  V Sklenár; T Dieckmann; S E Butcher; J Feigon
Journal:  J Biomol NMR       Date:  1996-01       Impact factor: 2.835

Review 8.  The emerging complexity of the tRNA world: mammalian tRNAs beyond protein synthesis.

Authors:  Paul Schimmel
Journal:  Nat Rev Mol Cell Biol       Date:  2017-09-06       Impact factor: 94.444

9.  Overexpression of bacterio-opsin in Escherichia coli as a water-soluble fusion to maltose binding protein: efficient regeneration of the fusion protein and selective cleavage with trypsin.

Authors:  G Q Chen; J E Gouaux
Journal:  Protein Sci       Date:  1996-03       Impact factor: 6.725

10.  DALRD3 encodes a protein mutated in epileptic encephalopathy that targets arginine tRNAs for 3-methylcytosine modification.

Authors:  Jenna M Lentini; Hessa S Alsaif; Eissa Faqeih; Fowzan S Alkuraya; Dragony Fu
Journal:  Nat Commun       Date:  2020-05-19       Impact factor: 14.919

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.